Researcher.Life Logo

Translational and Clinical Pharmacology : Impact Factor & More

eISSN: 2383-5427pISSN: 2289-0882

Key Metrics

CiteScore
2
H-Index
10
SJR
Q3Pharmacology (medical)
SNIP
0.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Translational and Clinical Pharmacology

Translational and Clinical Pharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher KSCPT
Frequency Quarterly
General Details
FrequencyQuarterly
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Translational and Clinical Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Translational and Clinical Pharmacology

The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lens.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Incidence and sex-related risk factors of linezolid-associated adverse drug reactions identified through electronic health records.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Pioneering pharmacometrics practice in Korea: an eight-year retrospective analysis of 192 projects from the first dedicated service organization (2016-2024).
  • 1 Mar 2026
  • Translational and clinical pharmacology
Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover study.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Erratum: A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg).
  • 1 Jan 2026
  • Translational and clinical pharmacology
The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lens.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Incidence and sex-related risk factors of linezolid-associated adverse drug reactions identified through electronic health records.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Pioneering pharmacometrics practice in Korea: an eight-year retrospective analysis of 192 projects from the first dedicated service organization (2016-2024).
  • 1 Mar 2026
  • Translational and clinical pharmacology
Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover study.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Erratum: A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg).
  • 1 Jan 2026
  • Translational and clinical pharmacology

FAQs on Translational and Clinical Pharmacology